Pierre Fabre
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- TOPAAL chewable tablet
- TOPAAL oral suspension
- B03 - Preparados antianémicos
- FER UCB oral solution 50 mg/5 ml
- TARDYFERON B9 prolonged-release tablet 256.3 mg(80 mg Fe++)+350 µg
- TARDYFERON coated tablet 256.3 mg (80 mg Fe++)
- C01 - Terapia cardíaca
- DIAFUSOR transdermal patch 10 mg/24 h
- DIAFUSOR transdermal patch 15 mg/24 h
- DIAFUSOR transdermal patch 5 mg/24 h
- MONICOR prolonged-release capsule, hard 60 mg
- M01 - Antiinflamatorios y antirreumáticos
- STRUCTUM capsule, hard 500 mg
- N06 - Psicoanalépticos
- IXEL capsule, hard 25 mg
- IXEL capsule, hard 50 mg